Ergostatrien-3β-ol suppresses breast cancer anoikis resistance and metastasis by targeting the miR-93-5p/leupaxin axis.

Saved in:
Bibliographic Details
Title: Ergostatrien-3β-ol suppresses breast cancer anoikis resistance and metastasis by targeting the miR-93-5p/leupaxin axis.
Authors: Rengamanar H; Graduate Institute of Biological Science and Technology, China Medical University, Taichung, Taiwan., Chen WC; Department of Medicine, MacKay Medical University, New Taipei, Taiwan; Division of Sports Medicine & Surgery, Department of Orthopaedic Surgery, MacKay Memorial Hospital, Taipei, Taiwan., Kuo YH; Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan; Chinese Medicine Research Center, China Medical University, Taichung, Taiwan., Tsai HC; Department of Medicine Research, China Medical University Beigang Hospital, Yunlin, Taiwan., Fong YC; Department of Sports Medicine, College of Health Care, China Medical University, Taichung, Taiwan; Department of Orthopedic Surgery, China Medical University Hospital, Taichung, Taiwan; Department of Orthopedic Surgery, China Medical University Beigang Hospital, Yunlin, Taiwan., Guo JH; Department of Neurosurgery, China Medical University Hospital, Taichung, Taiwan., Liu CL; Department of Neurosurgery, China Medical University Hospital, Taichung, Taiwan., Huang TM; Department of Chest Surgery, China Medical University Hospital, Taichung, Taiwan., Wu CY; School of Chinese Medicine, China Medical University, Taichung, Taiwan; Department of Neurosurgery, China Medical University Hsinchu Hospital, Hsinchu, Taiwan. Electronic address: 014345@tool.caaumed.org.tw., Tang CH; Chinese Medicine Research Center, China Medical University, Taichung, Taiwan; Department of Pharmacology, School of Medicine, China Medical University, Taichung, Taiwan; Department of Medical Laboratory Science and Biotechnology, College of Medical and Health Science, Asia University, Taichung, Taiwan. Electronic address: chtang@mail.cmu.edu.tw.
Source: European journal of pharmacology [Eur J Pharmacol] 2026 Jul 10; Vol. 1029, pp. 179022. Date of Electronic Publication: 2026 May 26.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur J Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0712
DOI:10.1016/j.ejphar.2026.179022